Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study
European Journal of Dermatology · 2024
DOI: 10.1684/ejd.2024.4693 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Sanghyuk Yoon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Basgenbio Inc., Seoul, South Korea. Hauptthemen laut MEDLINE: Skin Neoplasms, Mendelian Randomization Analysis, Psoriasis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Basgenbio Inc., Seoul, South Korea.
- Department of Dermatology, Jeonbuk National University Medical School, Jeonju, South Korea.
- Department of Medical Informatics, Jeonbuk National University, Jeonju, South Korea, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University H…
- Department of Dermatology, Jeonbuk National University Medical School, Jeonju, South Korea, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National Unive…
Zitieren
APA
Yoon, S., Lee, S. Y., Lee, G. J., Kim, J. S., Park, J., & Nam, K. H. (2024). Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4693
Vancouver
Yoon S, Lee SY, Lee GJ, Kim JS, Park J, Nam KH. Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4693
BibTeX
@article{Yoon2024,
author = {Yoon, Sanghyuk and Lee, Sun Yeop and Lee, Geon-Jong and Kim, Jong-Seung and Park, Jin and Nam, Kyung-Hwa},
title = {Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study},
journal = {European Journal of Dermatology},
year = {2024},
doi = {10.1684/ejd.2024.4693}
}
EUVIMED